Proteasomes Are Critical for Maintenance of CD133+CD24+ Kidney Progenitor Cells.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
27 Aug 2023
Historique:
received: 02 08 2023
revised: 19 08 2023
accepted: 25 08 2023
medline: 11 9 2023
pubmed: 9 9 2023
entrez: 9 9 2023
Statut: epublish

Résumé

Kidney progenitor cells, although rare and dispersed, play a key role in the repair of renal tubules after acute kidney damage. However, understanding these cells has been challenging due to the limited access to primary renal tissues and the absence of immortalized cells to model kidney progenitors. Previously, our laboratory utilized the renal proximal tubular epithelial cell line, RPTEC/TERT1, and the flow cytometry technique to sort and establish a kidney progenitor cell model called Human Renal Tubular Precursor TERT (HRTPT) which expresses CD133 and CD24 and exhibits the characteristics of kidney progenitors, such as self-renewal capacity and multi-potential differentiation. In addition, a separate cell line was established, named Human Renal Epithelial Cell 24 TERT (HREC24T), which lacks CD133 expression and shows no progenitor features. To further characterize HRTPT CD133+CD24+ progenitor cells, we performed proteomic profiling which showed high proteasomal expression in HRTPT kidney progenitor cells. RT-qPCR, Western blot, and flow cytometry analysis showed that HRTPT cells possess higher proteasomal expression and activity compared to HREC24T non-progenitor cells. Importantly, inhibition of the proteasomes with bortezomib reduced the expression of progenitor markers and obliterated the potential for self-renewal and differentiation of HRTPT progenitor cells. In conclusion, proteasomes are critical in preserving progenitor markers expression and self-renewal capacity in HRTPT kidney progenitors.

Identifiants

pubmed: 37686107
pii: ijms241713303
doi: 10.3390/ijms241713303
pmc: PMC10487892
pii:
doi:

Substances chimiques

CD24 Antigen 0
CD24 protein, human 0
Proteasome Endopeptidase Complex EC 3.4.25.1
AC133 Antigen 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIGMS NIH HHS
ID : P20 GM103442
Pays : United States
Organisme : NIGMS NIH HHS
ID : R24 GM137786
Pays : United States

Références

Stem Cell Res. 2013 Nov;11(3):1163-77
pubmed: 24012544
Cell Stem Cell. 2008 Mar 6;2(3):284-91
pubmed: 18371453
Toxicol Appl Pharmacol. 2017 Sep 15;331:116-129
pubmed: 28587817
Stem Cells. 2012 Aug;30(8):1714-25
pubmed: 22628275
N Engl J Med. 2003 Jun 26;348(26):2609-17
pubmed: 12826635
J Am Soc Nephrol. 2006 Sep;17(9):2443-56
pubmed: 16885410
World J Stem Cells. 2016 Nov 26;8(11):367-375
pubmed: 27928463
Nat Rev Nephrol. 2013 Mar;9(3):137-46
pubmed: 23338209
Nature. 2012 Sep 13;489(7415):304-8
pubmed: 22972301
Kidney Int. 2016 Apr;89(4):792-808
pubmed: 26924053
Histol Histopathol. 2011 Feb;26(2):223-32
pubmed: 21154236
Bioinformatics. 2002;18 Suppl 1:S96-104
pubmed: 12169536
Int J Mol Sci. 2023 May 23;24(11):
pubmed: 37298099
Stem Cells Transl Med. 2018 Mar;7(3):283-294
pubmed: 29431914
J Pathol. 2013 Apr;229(5):645-59
pubmed: 23124355
Stem Cell Res. 2014 May;12(3):828-9
pubmed: 24467938
J Am Soc Nephrol. 2009 Feb;20(2):322-32
pubmed: 19092120
ACS Omega. 2020 Sep 30;5(40):25625-25633
pubmed: 33073088
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Dev Cell. 2018 Jun 4;45(5):651-660.e4
pubmed: 29870722
BMB Rep. 2012 May;45(5):299-304
pubmed: 22617454
Int J Stem Cells. 2019 Nov 30;12(3):463-473
pubmed: 31474027
Toxicol Appl Pharmacol. 2019 Jul 15;375:5-16
pubmed: 31078587
Kidney Int. 2002 Jul;62(1):237-44
pubmed: 12081583
Cell Death Differ. 2016 Aug;23(8):1257-64
pubmed: 27285106
Cell Stem Cell. 2012 Dec 7;11(6):783-98
pubmed: 23103054
Stem Cell Res Ther. 2014 Feb 18;5(1):24
pubmed: 25127410
Proc Jpn Acad Ser B Phys Biol Sci. 2009;85(1):12-36
pubmed: 19145068
J Am Soc Nephrol. 2007 Dec;18(12):3128-38
pubmed: 17978305
Am J Pathol. 2011 Feb;178(2):828-37
pubmed: 21281815
Toxicol Appl Pharmacol. 2019 Jul 1;374:41-52
pubmed: 31047981
Br J Haematol. 2004 Oct;127(2):165-72
pubmed: 15461622
Am J Pathol. 2005 Feb;166(2):545-55
pubmed: 15681837
Anal Chem. 2003 Sep 1;75(17):4646-58
pubmed: 14632076
J Cell Mol Med. 2021 Nov;25(22):10466-10479
pubmed: 34626063
BMC Genomics. 2009 Jan 08;10:10
pubmed: 19128516
Kidney Int. 2016 Aug;90(2):289-299
pubmed: 27234568
Sci Rep. 2018 Mar 6;8(1):4092
pubmed: 29511261
J Am Soc Nephrol. 2018 Aug;29(8):2069-2080
pubmed: 29980650
Am J Physiol Renal Physiol. 2008 Nov;295(5):F1365-75
pubmed: 18715936
J Cell Mol Med. 2020 Aug;24(16):9428-9438
pubmed: 32628811

Auteurs

Sarmad Al-Marsoummi (S)

Department of Pathology, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA.

Aaron A Mehus (AA)

Department of Pathology, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA.

Swojani Shrestha (S)

Department of Pathology, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA.

Rayna Rice (R)

Department of Pathology, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA.

Brooke Rossow (B)

Department of Pathology, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA.

Seema Somji (S)

Department of Pathology, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA.

Scott H Garrett (SH)

Department of Pathology, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA.

Donald A Sens (DA)

Department of Pathology, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH